Reading Time: 5 minutesTherapy By Elena Schmidt Lykos’ psychedelic-assisted therapy model was meant to reinvent mental healthcare as
Reading Time: 2 minutesCompass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based
Reading Time: 2 minutesIt’s no secret that psychedelic experiences can make people think differently, resulting in more open-mindedness
Reading Time: 2 minutesCompass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based
Reading Time: < 1 minuteThere are many different aspects to consider when integrating a psychedelic experience, and many tools
Reading Time: 5 minutesCompass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to
Reading Time: 3 minutesMelodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’), is pleased to announce a non-binding
Reading Time: 2 minutesMelodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it
Reading Time: 5 minutesOverview The global regulatory climate around cannabis use is evolving and has resulted in a
Reading Time: 8 minutesBusiness highlights COMP360 psilocybin treatment in treatment-resistant depression (TRD): Phase 3 program ongoing, composed of